Connect with a Global Community of 120+ T-Cell Engager Experts
As the only event exclusively dedicated to innovating safer and more effective T-Cell Engagers in solid tumors and autoimmunity, this forum offers an unparalleled opportunity for industry leaders to engage with top experts from large pharma and biotech, all focused on proving that TCEs are set to become the new standard of care treatment for solid tumors.
With a growing demand for antibody engineering and design services, advanced models indicative of the human immune system and sensitive assays to demonstrate the safety and efficacy of TCEs, this forum is the ideal setting to identify market gaps that products and services could address.
Recent breakthroughs in the field, such as Xencor's initial positive data for their first-in-class ENPP3 X CD3 bispecific T-cell engager, have sparked excitement in the immune resetting landscape. As the field ramps up, there is momentum for a major shift in how solid tumors and autoimmune conditions are treated.
This event provides a unique chance to position your services in front of drug developers at the forefront of these developments, aligning with the most cutting-edge research and development in autoimmunity. It is the perfect moment to establish valuable partnerships and showcase contributions to advance transformative solutions for the huge solid tumor patient population.
What to Expect?
Meet New Clients
Shake hands with the who’s who of T-Cell Engager-focused drug development and gain unparalleled opportunities for high-level networking with influential decision-makers and pioneers driving the future of immune-oncology and treatment innovation.
Raise Your Brand Awareness
Position your brand in front of key immune-oncology drug developers who are actively seeking innovative services, unlocking new business prospects, and fostering valuable connections with industry leaders.
Showcase Your Solutions
This market is open to novel approaches, and this event offers a prime stage to demonstrate how your immune-oncology models, antibody design & engineering services and bespoke safety and efficacy assays can provide essential insights, support drug development and improve treatment outcomes, positioning your solutions as key to advancing the field.
Gain Market Intelligence
Stay ahead of industry trends by hearing directly from KOLs. Gain insights and competitor strategies to shape your organization’s future and sharpen its competitive edge.
Key Interest Areas
Our attendees from immune resetting focused drug development are looking for service and solution providers with capabilities in the below areas but not limited to:
Antibody Discovery, Design and Engineering Providers
Immuno-oncology Models
Immunology & Immunogenicity Assays
Hear What Our Past Sponsors Have to Say
Intimate environment made it easy to network with other attendees
Applied Biomath
Innovative talks and great networking sessions
Nextera
Audience Composition
Company Type
Attending Companies Include
Available Inventory
We have a range of inventory from standard booth and speaking slots to more bespoke deliverables such as badges, exclusive dinners and tours to help elevate your brand.
Get in Touch
Take advantage of our bespoke sponsorship opportunities to achieve your commercial goals. Email us if you would like to get involved and discuss a bespoke package suited to your needs.
Samuel Turner
Partnerships Director